Patten Group’s Immunogen Inc IMGN Stock Holding History

Patten Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-31	Closed	–	–	568
2018 Q4	$0	Buy	+31	New	+$188	﹤0.01%	705
2016 Q4	–	Sell	-1,000	Closed	-$2.41K	–	640
2016 Q3	$2.41K	Buy	+1,000	New	+$2.91K	﹤0.01%	571

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Patten Group's IMGN Position: Q1 2019 in Review

Patten Group sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 31 shares.

Patten Group first reported a position in IMGN in Q3 2016 and held it in 2 quarters. The position peaked at $2.41K in Q3 2016. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

Patten Group reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
Patten Group sold 31 Immunogen Inc shares in Q1 2019.
Patten Group first reported a position in Immunogen Inc in Q3 2016 and held it in 2 quarters.
Patten Group's Immunogen Inc position peaked at $2.41K in Q3 2016.
212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.